Literature DB >> 12459385

Towards integrating functional imaging in the treatment of prostate cancer with radiation: the registration of the MR spectroscopy imaging to ultrasound/CT images and its implementation in treatment planning.

Takashi Mizowaki1, Gil'ad N Cohen, Albert Y C Fung, Marco Zaider.   

Abstract

PURPOSE: Dose-escalation to intraprostatic tumor deposits detected by magnetic resonance spectroscopy (MRS) is an example of tumor-targeted radiation therapy. Because treatment planning for prostate brachytherapy is performed based on ultrasound (US)/computed tomography (CT) images, a sine qua non of this technique is the ability to map MRS-positive volumes (obtained in a gland deformed by the endorectal balloon coil) to the US/CT images. An empirical algorithm designed to perform this function, and its validation, are described. METHODS AND MATERIALS: Mathematically, the problem of mapping points between the MR and US/CT domains comes to: (a) ascertaining that the position of any point in the interior of the prostate is uniquely determined by the shape of the gland, and (b) finding an algorithm that describes this relationship. The image registration algorithm described here is based on the assumption that points within the gland maintain the same relative position with respect to both the axial contours of the prostate and the center of the prostate along the superior-inferior direction. Relative positions of MRS-positive voxels are calculated with this method in both MR and US/CT space. For a particular voxel in the MR space, one obtains first the z coordinate in the US/CT space, that is, along the superior-inferior direction. This determines the axial slice in the US/CT frame of reference where the other two coordinates (x, y) will be calculated. The validity of this algorithm was examined with the aid of a pelvic phantom built to simulate realistically the prostate and its surrounding bony and tissue structures and with CT scans of implanted patients obtained, at several weeks' intervals, as part of an edema-resolution study. Seventy-five "dummy" seeds were placed in the phantom, within the simulated prostate gland, in a quasi-regular pattern. The coordinates of these seeds were determined and thus served as markers of prostate deformation when an inflated rectal probe was introduced in the phantom. CT images of this phantom were taken for different volumes of the MR rectal probe and in each case the prostate outlines were contoured and seed coordinates calculated. Using these data, the predictions of the mapping algorithm could be directly verified.
RESULTS: Absolute values of the 3D-positional errors in this algorithm were 2.2 mm +/- 1.2 mm (average +/- SD). Only 6 of 75 seeds had positional displacement of 4 mm or more. Similar results were obtained in the patient analysis.
CONCLUSIONS: In comparison to the MRS voxel size (6.25 x 6.25 x 3.0 mm3), the present algorithm achieves the desired clinical accuracy. As well, with this 3D algorithm seed positions are reconstructed with an uncertainty that, along the z direction, is less than half the thickness of the typical US slice (0.5 cm).

Entities:  

Mesh:

Year:  2002        PMID: 12459385     DOI: 10.1016/s0360-3016(02)03805-1

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  15 in total

1.  System for prostate brachytherapy and biopsy in a standard 1.5 T MRI scanner.

Authors:  Robert C Susil; Kevin Camphausen; Peter Choyke; Elliot R McVeigh; Gary S Gustafson; Holly Ning; Robert W Miller; Ergin Atalar; C Norman Coleman; Cynthia Ménard
Journal:  Magn Reson Med       Date:  2004-09       Impact factor: 4.668

2.  Transrectal prostate biopsy and fiducial marker placement in a standard 1.5T magnetic resonance imaging scanner.

Authors:  Robert C Susil; Cynthia Ménard; Axel Krieger; Jonathan A Coleman; Kevin Camphausen; Peter Choyke; Gabor Fichtinger; Louis L Whitcomb; C Norman Coleman; Ergin Atalar
Journal:  J Urol       Date:  2006-01       Impact factor: 7.450

3.  Fused radioimmunoscintigraphy for treatment planning.

Authors:  Rodney J Ellis; Deborah A Kaminsky
Journal:  Rev Urol       Date:  2006

Review 4.  MR-guided prostate interventions.

Authors:  Clare Tempany; Sarah Straus; Nobuhiko Hata; Steven Haker
Journal:  J Magn Reson Imaging       Date:  2008-02       Impact factor: 4.813

Review 5.  Is it time to consider a role for MRI before prostate biopsy?

Authors:  Hashim U Ahmed; Alex Kirkham; Manit Arya; Rowland Illing; Alex Freeman; Clare Allen; Mark Emberton
Journal:  Nat Rev Clin Oncol       Date:  2009-04       Impact factor: 66.675

6.  Prostate multimodality image registration based on B-splines and quadrature local energy.

Authors:  Jhimli Mitra; Robert Martí; Arnau Oliver; Xavier Lladó; Soumya Ghose; Joan C Vilanova; Fabrice Meriaudeau
Journal:  Int J Comput Assist Radiol Surg       Date:  2011-06-26       Impact factor: 2.924

7.  Enhancing the utility of prostascint SPECT scans for patient management.

Authors:  Marilyn E Noz; Grace Chung; Benjamin Y Lee; Gerald Q Maguire; J Keith DeWyngaert; Jay V Doshi; Elissa L Kramer; Antoinette D Murphy-Walcott; Michael P Zeleznik; Noeun G Kwak
Journal:  J Med Syst       Date:  2006-04       Impact factor: 4.460

8.  Long-term outcome of magnetic resonance spectroscopic image-directed dose escalation for prostate brachytherapy.

Authors:  Martin T King; Nicola J Nasser; Nitin Mathur; Gil'ad N Cohen; Marisa A Kollmeier; Jasper Yuen; Hebert A Vargas; Xin Pei; Yoshiya Yamada; Kristen L Zakian; Marco Zaider; Michael J Zelefsky
Journal:  Brachytherapy       Date:  2016-04-20       Impact factor: 2.362

9.  Registration of in vivo prostate MRI and pseudo-whole mount histology using Local Affine Transformations guided by Internal Structures (LATIS).

Authors:  Chaitanya Kalavagunta; Xiangmin Zhou; Stephen C Schmechel; Gregory J Metzger
Journal:  J Magn Reson Imaging       Date:  2014-04-04       Impact factor: 4.813

Review 10.  Current role and future perspectives of magnetic resonance spectroscopy in radiation oncology for prostate cancer.

Authors:  Aleksandra Zapotoczna; Giuseppe Sasso; John Simpson; Mack Roach
Journal:  Neoplasia       Date:  2007-06       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.